Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Osteoarthritis, Spondylitis, Thrombosis
Clinical narrative: developed a blood clot in her stomach that went away after 2 weeks; an arthritic toe; Arthritis in neck; This spontaneous case was reported by a patient and describes the occurrence of THROMBOSIS (developed a blood clot in her stomach that went away after 2 weeks) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Suspected COVID-19 (Not sure but may have had in February or March of 2020 Treatment received: antibiotics) in 2020. Concurrent medical conditions included Blood pressure high (history of high blood pressure prior to getting any doses).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced THROMBOSIS (developed a blood clot in her stomach that went away after 2 weeks) (seriousness criterion medically significant), OSTEOARTHRITIS (an arthritic toe) and SPONDYLITIS (Arthritis in neck). In 2021, THROMBOSIS (developed a blood clot in her stomach that went away after 2 weeks) had resolved. At the time of the report, OSTEOARTHRITIS (an arthritic toe) and SPONDYLITIS (Arthritis in neck) outcome was unknown.            No concomitant medication was reporter.  The patient developed a blood clot in stomach that went away after 2 weeks, an arthritic toe and  arthritis in patients neck that comes and goes. No treatment medication was not reporter.  Company Comment: This is a Spontaneous case concerning a 75-year-old female patient with no relevant medical history reported, who experienced the serious (medically significant) unexpected AESI of Thrombosis (reported as: blood clot in her stomach) and non-serious unexpected AESI of Spondylitis which occurred after the primary series of vaccination with mRNA-1273 on the same year but unknown exact onset latency. It was reported that the event of blood clot resolved after two weeks, no relevant diagnostic test, concomitant medications or treatment was reported. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.   This case was linked to MOD-2022-607347 (Patient Link).; Sender's Comments: This is a Spontaneous case concerning a 75-year-old female patient with no relevant medical history reported, who experienced the serious (medically significant) unexpected AESI of Thrombosis (reported as: blood clot in her stomach) and non-serious unexpected AESI of Spondylitis which occurred after the primary series of vaccination with mRNA-1273 on the same year but unknown exact onset latency. It was reported that the event of blood clot resolved after two weeks, no relevant diagnostic test, concomitant medications or treatment was reported. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.